"This is the technology that makes ALNX a $90 stock."
What does that mean?!
This is typical of a rehdvm post - copying and pasting information he isn't actually mentally processing. Hence the nickname of Budgie.
A company with 10 million shares outstanding and a share price of $90 has a market capitalisation of $900 million - a lot higher than the current Insmed market cap of $240 million, but still a minnow compared with Pfizer with its market cap of $175 billion.
Fwiw - Alexion has a lot more shares outstanding than 10 million, and has a market cap of one-tenth that of Pfizer.
For somebody who is such an advocate of facing the facts, it's a real irony (not to mention a major bore) that he himself has never faced the fact that his veterinarian qualifications leave him a long way short when it comes to offering advice in an investment forum.
What with Bizarro Boy wittering on about fiscal cliffs - another individual who seems blissfully unaware of how unqualified he is to offer investment advice - we seem to have an unhappy knack of attracting individuals suffering from delusions of adequacy.